25308-67-2Relevant articles and documents
-
Sonoda,A. et al.
, p. 1777 - 1781 (1972)
-
APOPTOSIS-INDUCED AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
-
Paragraph 1157, (2013/04/24)
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.
Pyrrolopyrazinyl Urea Kinase Inhibitors
-
Page/Page column 43, (2010/06/19)
The present invention relates to the use of novel pyrrolopyrazinyl urea derivatives of Formula I, wherein the variables R1, R2, R3, R4, and R5 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.